TW200636067A - Mutant porcine reproductive and respiratory syndrome virus - Google Patents

Mutant porcine reproductive and respiratory syndrome virus

Info

Publication number
TW200636067A
TW200636067A TW094139421A TW94139421A TW200636067A TW 200636067 A TW200636067 A TW 200636067A TW 094139421 A TW094139421 A TW 094139421A TW 94139421 A TW94139421 A TW 94139421A TW 200636067 A TW200636067 A TW 200636067A
Authority
TW
Taiwan
Prior art keywords
respiratory syndrome
syndrome virus
porcine reproductive
mutant porcine
mutant
Prior art date
Application number
TW094139421A
Other languages
English (en)
Inventor
Dong-Wan Yoo
Chang-Hee Lee
Jay Gregory Calvert
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TW200636067A publication Critical patent/TW200636067A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/04—Inactivation or attenuation; Producing viral sub-units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10041—Use of virus, viral particle or viral elements as a vector
    • C12N2770/10043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/10011—Arteriviridae
    • C12N2770/10061—Methods of inactivation or attenuation

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Plant Pathology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW094139421A 2004-11-11 2005-11-10 Mutant porcine reproductive and respiratory syndrome virus TW200636067A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62676704P 2004-11-11 2004-11-11

Publications (1)

Publication Number Publication Date
TW200636067A true TW200636067A (en) 2006-10-16

Family

ID=36061457

Family Applications (1)

Application Number Title Priority Date Filing Date
TW094139421A TW200636067A (en) 2004-11-11 2005-11-10 Mutant porcine reproductive and respiratory syndrome virus

Country Status (16)

Country Link
US (1) US7879337B2 (zh)
EP (1) EP1812573A1 (zh)
JP (1) JP2008519594A (zh)
KR (1) KR20070064666A (zh)
CN (1) CN101056982A (zh)
AR (1) AR051487A1 (zh)
AU (1) AU2005303510B2 (zh)
BR (1) BRPI0517745A (zh)
CA (1) CA2586153C (zh)
IL (1) IL182976A0 (zh)
MX (1) MX2007005708A (zh)
NO (1) NO20072578L (zh)
RU (1) RU2007117510A (zh)
TW (1) TW200636067A (zh)
WO (1) WO2006051396A1 (zh)
ZA (1) ZA200703762B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8404253B2 (en) * 2006-12-28 2013-03-26 Newport Laboratories, Inc. Modified live (JMSO strain) Haemophilus parasuis vaccine
MY186535A (en) * 2011-02-17 2021-07-26 Boehringer Ingelheim Vetmedica Gmbh Novel european prrsv strain
CN109876139A (zh) * 2012-04-24 2019-06-14 俄亥俄州国家创新基金会 用于治疗和预防猪繁殖与呼吸综合征的组合物和方法
CN115851614A (zh) * 2021-09-23 2023-03-28 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) 猪繁殖与呼吸综合征病毒复制缺陷型疫苗株及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132106B2 (en) 1998-12-22 2006-11-07 Pfizer Inc. Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
NZ501264A (en) 1998-12-22 2001-09-28 Pfizer Prod Inc Polynucleotide DNA sequence encoding an infectious RNA molecule encoding a North American PRRS
DK1183332T3 (da) * 1999-04-22 2010-09-06 Us Agriculture Porcint Reproduktions- og Respirations Syndrom-vaccine baseret på isolere JA-142
WO2002095040A1 (en) 2001-05-21 2002-11-28 Id-Lelystad, Instituut Voor Dierhouderij En Diergezondheid B.V. Delections in arterivirus replicons
US20020012670A1 (en) * 2000-01-26 2002-01-31 Knut Elbers Recombinant attenuation of porcine reproductive and respiratory syndrome (PRRSV)
US6841364B2 (en) * 2002-01-22 2005-01-11 Protatek International, Inc. Infectious cDNA clones of porcine reproductive and respiratory syndrome virus and expression vectors thereof
EP1438969A1 (en) 2003-01-14 2004-07-21 Universiteit Utrecht Arterivirus marker vaccine

Also Published As

Publication number Publication date
CA2586153C (en) 2012-04-03
CN101056982A (zh) 2007-10-17
KR20070064666A (ko) 2007-06-21
ZA200703762B (en) 2008-09-25
IL182976A0 (en) 2007-08-19
AR051487A1 (es) 2007-01-17
CA2586153A1 (en) 2006-05-18
US7879337B2 (en) 2011-02-01
EP1812573A1 (en) 2007-08-01
NO20072578L (no) 2007-08-02
US20090004221A1 (en) 2009-01-01
RU2007117510A (ru) 2008-11-20
MX2007005708A (es) 2007-07-09
WO2006051396A1 (en) 2006-05-18
AU2005303510B2 (en) 2011-02-03
BRPI0517745A (pt) 2008-10-21
JP2008519594A (ja) 2008-06-12
AU2005303510A1 (en) 2006-05-18

Similar Documents

Publication Publication Date Title
TW200641126A (en) N protein mutants of porcine reproductive and respiratory syndrome virus
FR20C1016I1 (zh)
PL1951882T3 (pl) Kwasy nukleinowe kodujące szczepionkę przeciwko wirusowi wywołującemu zespół zaburzeń reprodukcyjnych i oddechowych u świń
EP1794329A4 (en) ISOLATES OF PORCINE RESPIRATORY DYSGENESIS SYNDROME (SDRP), AND METHODS OF USE
MXPA03008961A (es) Composicion de vacuna.
GB0325849D0 (en) Rear projection screen,and rear projection system using the screen
TW200727920A (en) New regimens for oral monophasic contraceptives
MX2008001652A (es) Copolimeros de poliamonio-polisiloxano.
GB0123724D0 (en) Elevation mechanism for armchair armrest
IL176328A0 (en) Method for purifying fsh
ZA200210230B (en) Porcine reproductive and respiratory syndrome virus (PRRSV) recombinant avipoxvirus vaccine.
NO20065115L (no) Cellulaer tillatende faktor for virus, og anvendelse derav
MXPA03007915A (es) Vacuna.
ZA200407043B (en) Grouping, synchronisation and compaction mechanism.
TW200636067A (en) Mutant porcine reproductive and respiratory syndrome virus
ATE418530T1 (de) Kompaktiertes menthol
ZA200803558B (en) Marked bovine viral diarrhea virus vaccines
EP1718330A4 (en) COMPLEX POLYPEPTIDE AND ADJUVANT FOR ENHANCED VACCINES
AU2003209345A8 (en) Attenuated mycobacterium tuberculosis vaccines
MX2009003300A (es) Vectores de rhinovirus recombinantes.
MXPA03007838A (es) Interferon alfa modificado con inmunogenicidad reducida.
TW200604714A (en) Method for designing a discharge lamp
UA89660C2 (ru) Мутанты n-протеина вируса репродуктивного и респираторного синдрома свиней
HUP0401182A3 (en) Vaccine composition comprising at least two valences, one enhanced with adjuvant and not the other
MXPA03007625A (es) Trombopoyetina modificada con inmunogenicidad reducida.